Tag: Patented Medicine Prices Review Board

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Patented Medicine Prices Review Board

Canada: "This Court Does Not Sign Blank Cheques": Federal Court Of Appeal Reverses Canada's ...

Added to Collection on: 2021-08-05 09:50:36

Tags for this article:

Health care
Life Sciences
Eculizumab
Immunosuppressants
Drugs
Alexion Pharmaceuticals
Canada (Minister of Citizenship and Immigration) v Vavilov
Canadian administrative law
Patented Medicine Prices Review Board
Pricing
Alexion Pharmaceuticals Inc.
Soliris
Canada

Click the tags to see associated articles and topics

View Article Details
Improvements needed in Canada's regulatory environment

Added to Collection on: 2021-08-13 15:22:30

Tags for this article:

Health sciences
Life Sciences
Articles
Pharmaceutical industry
Biomanufacturing
Biopharmaceuticals
Biotechnology
Food industry
Medication
Access to medicines
Vaccine
Patented Medicine Prices Review Board
Canada

Click the tags to see associated articles and topics

View Article Details
FCA remits pricing decision on ALEXION'S SOLIRIS to PMPRB | Smart & Biggar - JDSupra

Added to Collection on: 2021-08-25 13:41:15

Tags for this article:

Health care
Life Sciences
Eculizumab
Immunosuppressants
Drugs
Alexion Pharmaceuticals
Patented Medicine Prices Review Board
Pricing
Soliris
Alexion Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
PMPRB Update: Supreme Court Refuses To Hear Appeal From Decision Restricting ...

Added to Collection on: 2022-03-29 14:46:33

Tags for this article:

Life Sciences
Health care
Anti-competitive practices
Eculizumab
Immunosuppressants
United States patent law
United States antitrust law
Drugs
Alexion Pharmaceuticals
Pricing
Monopoly
Patented Medicine Prices Review Board
Canada

Click the tags to see associated articles and topics

View Article Details
Retirement-age employees fear low interest rates, rising inflation will impact retirement income

Added to Collection on: 2022-04-19 17:55:17

Tags for this article:

Medication
Pharmaceutical industry
Jean-Yves Duclos
Duclos
Patented Medicine Prices Review Board
Health sciences
Natural sciences
Health care
COVID-19 pandemic in England
In England
Pharmaceuticals policy

Click the tags to see associated articles and topics

View Article Details
Canada: May 1 Deadline To Seek Leave To Intervene In PMPRB SOLIRIS Rehearing - Mondaq

Added to Collection on: 2022-04-30 09:33:37

Tags for this article:

Drugs
Eculizumab
Immunosuppressants
Intervention
Rehearing
Patented Medicine Prices Review Board
Intervener
Health care
R (Miller) v Secretary of State for Exiting the European Union
Medical specialties
Alexion

Click the tags to see associated articles and topics

View Article Details
PMPRB Regulations: New Basket Of Comparator Countries Has Arrived, Absent Guidance

Added to Collection on: 2022-07-09 09:34:20

Tags for this article:

Health care
Articles
Health
Eculizumab
Immunosuppressants
Alexion Pharmaceuticals
Patented Medicine Prices Review Board
Medical guideline
Déjà vu
Canada

Click the tags to see associated articles and topics

View Article Details
How to use the regulatory data from Health Canada for secondary analyses on new drugs ...

Added to Collection on: 2023-11-21 05:05:29

Tags for this article:

Canadian Institutes of Health Research
Health Canada
Honorarium
Patented Medicine Prices Review Board
The BMJ
Laura

Click the tags to see associated articles and topics

View Article Details
Patented Medicine Prices Review Board Issues a Notice of Hearing for Allegations of ...

Added to Collection on: 2024-04-02 19:40:49

Tags for this article:

Eculizumab
Immunosuppressants
Alexion Pharmaceuticals
Patented Medicine Prices Review Board
Medication
Atypical hemolytic uremic syndrome
Pricing
Pharmaceutical industry
Alexion Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Discussion Guide For PMPRB Phase 2 Consultations On New Guidelines Outlines ... - Mondaq

Added to Collection on: 2024-07-31 12:12:26

Tags for this article:

Pharmaceuticals policy
Competition
External reference pricing
Medication
Patented Medicine Prices Review Board
Pricing
Over-the-counter drug

Click the tags to see associated articles and topics

View Article Details